IMMU-34. CONTROLLED EXPRESSION OF IL-12 IMPROVES SURVIVAL IN GLIOMA BY ACTIVATING THE IMMUNE RESPONSE IN MICE AND HUMANS

von Barrett, John, Cai, Hongliang, Miao, John, Khare, Pranay, Chan, Tim, Cooper, Laurence, Lebel, Francois
Veröffentlicht in Neuro Oncol (2017)

IMMU-33. CONTROLLED LOCAL EXPRESSION OF IL-12 AS GENE THERAPY CONCOMITANT WITH SYSTEMIC CHEMOTHERAPY IMPROVES SURVIVAL IN GLIOMA

von Barrett, John, Cai, Hongliang, Miao, John, Khare, Pranay, Dalsing-Hernandez, Jessica, Gonzales, Paul, Chan, Tim, Cooper, Laurence, Lebel, Francois
Veröffentlicht in Neuro Oncol (2017)

Regulated intratumoral expression of IL-12 using a RheoSwitch Therapeutic System(®) (RTS(®)) gene switch as gene therapy for the treatment of glioma

von Barrett, John A., Cai, Hongliang, Miao, John, Khare, Pranay D., Gonzalez, Paul, Dalsing-Hernandez, Jessica, Sharma, Geeta, Chan, Tim, Cooper, Laurence J.N, Lebel, Francois
Veröffentlicht in Cancer Gene Ther (2018)

Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor modified T cell infusions for liver metastases

von Saied, Abdul, Licata, Lauren, Burga, Rachel A., Thorn, Mitchell, McCormack, Elise, Stainken, Brian F., Assanah, Earle O., Khare, Pranay D., Davies, Robin, Espat, N. Joseph, Junghans, Richard P., Katz, Steven C.
Veröffentlicht in Cancer Gene Ther (2014)

Phase I Hepatic Immunotherapy for Metastases study of intra-arterial chimeric antigen receptor modified T cell therapy for CEA+ liver metastases

von Katz, Steven C., Burga, Rachel A., McCormack, Elise, Wang, Li Juan, Mooring, Wesley, Point, Gary, Khare, Pranay D., Thorn, Mitchell, Ma, Qiangzhong, Stainken, Brian F., Assanah, Earle O., Davies, Robin, Espat, N. Joseph, Junghans, Richard P.
Veröffentlicht in Clin Cancer Res (2015)